Cancer Care - St. Luke's Mountain States Tumor Institute
Research and Clinical Trials

Because of its nationally respected expertise, MSTI is asked to participate in numerous clinical research protocols in cooperation with regional and national cancer research groups and pharmaceutical firms.

Among these research groups are the National Cancer Institute, Fred Hutchison Cancer Center, Mountain States Medical Research Institute, Children's Oncology Group, Puget Sound Oncology Consortium, and the Southwest Oncology Group, all of which share important information about the latest developments in cancer treatments that benefit patients.

MSTI was selected to participate as a satellite of the University of Utah in the PLCO (Prostate, Lung, Colorectal and Ovarian) Cancer Screening Trial, a long-term study sponsored by the National Cancer Institute (NCI). This study is designed to determine if screening tests intended to detect these cancers at an early stage will be able to reduce deaths from these malignancies. The trial will also help researchers learn more about the causes of these cancers and how to prevent them in the future.

Since October 2002 MSTI has been actively involved in The National Lung Screening Trial. Study participants are randomly assigned to receive either a chest X-ray or a spiral CT once a year for three years. The purpose of the study is to compare the effectiveness of chest x-ray to spiral CT in early detection of lung cancer and in reducing the number of deaths from this disease. There is extensive information on this web site about lung cancer and links to other resources. http://www.nci.nih.gov/NLST for more information call: 1-800-716-0499

MSTI was selected to participate in the largest cancer prevention trial ever undertaken. This clinical research trial, known as SELECT, evaluates the affect of selenium and vitamin E in the prevention of prostate cancer. The overall goal is to enroll 32,000 male patients in a five-year period and to follow each patient for many years to determine the impact of treatment on the likelihood of development of prostate cancer.

Research efforts at MSTI are important in the development of new drugs and procedures to improve cancer treatment results and to reduce side effects as well as for developing methods and techniques helpful in the early detection and/or prevention of cancer.

Interested in clinical trials?
Mountain States Tumor Institute is pleased to offer TrialCheck ®. TrialCheck is a free comprehensive searchable database of cancer clinical trials that offers the very latest in treatment information.

With TrialCheck, patients and caregivers can easily locate clinical trials based on patient-specific criteria such as cancer types, stage, previous treatment, daily activity and zip code.